Lv1
68 积分 2025-05-06 加入
Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis
11天前
已完结
Family planning considerations in people with multiple sclerosis
12天前
已完结
Spinal Cord Atrophy in Neuromyelitis Optica Spectrum Disorders Is Spatially Related to Cord Lesions and Disability
22天前
已完结
Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study
1个月前
已完结
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease
1个月前
已完结
Obexelimab and the Promise of Nondepleting B-Cell Therapy in IgG4-Related Disease
1个月前
已完结
Can Once-Yearly Rituximab Dosing Be "Enough" for Most People With Relapsing Multiple Sclerosis?
2个月前
已完结
Predicting visual outcomes in keratoprosthesis surgery with critical flicker fusion frequency, B-scan, visual electrophysiology and endoscopy
3个月前
已关闭
Acute eculizumab treatment in a pediatric patient with AQP4-IgG+ NMOSD
6个月前
已完结
Unveiling Misdiagnosis: Rethinking Seronegative NMOSD
7个月前
已完结
皖公网安备34019202002308
